Speaker illustration

Professor Marja-Riitta Taskinen

University of Helsinki, Helsinki (Finland)

Member of:

European Society of Cardiology

Marja-Riitta Taskinen MD, PhD is an Emerita Professor of Medicine and her team is a member of the Research Program for Clinical and Molecular Metabolism, Biomedicum Helsinki, University of Helsinki. Her research focus is on lipoprotein metabolism, dyslipidemias and recently NAFLD. She has over 430 original publications and 130 reviews and chapters (H-index 97). Her outstanding achievements have been recognized by several international awards including the Claude Bernard Award (EASD 2002), Edwin Bierman Award (ADA 2004) and Novartis Award (2006). She was selected as Robert Levy Memorial Lecturer by American Heart Association (AHA 2017) and she was selected as EASD honorary member in 2017. She has been involved in activities of European Atherosclerosis Society (President of EAS 2006-2008) as well as of the EASD and IDF. She is ESC fellow and a member of the EAS/ESC Guidelines committee on Management of dyslipidemias.

Controversies in secondary prevention: treating residual risk

Event: ESC Congress 2019

Topic: Prevention

Session type: Debate Session

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb